⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6014383 | 0.93 | NFKB1 (0.42) | — | |
| SCHEMBL19547960 | 0.84 | TBXAS1 (0.48) | — | |
| SCHEMBL4972648 | 0.84 | TBXAS1 (0.44) | — | |
| SCHEMBL7206466 | 0.80 | — | — | |
| SCHEMBL4972765 | 0.78 | TBXAS1 (0.38) | — | |
| SCHEMBL15141520 | 0.75 | — | — | |
| SCHEMBL4970367 | 0.75 | PTPN7 (0.50) | — | |
| SCHEMBL1088162 | 0.75 | — | — | |
| SCHEMBL9746630 | 0.75 | — | — | |
| SCHEMBL15548365 | 0.75 | TBXAS1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10471057-B2 | Toxic RNA inhibitors self-assembled in situ | THE SCRIPPS RESEARCH INSTITUTE (US) | 2019-11-12 | — | — | US | disclosed |
| US-20190151310-A1 | TOXIC RNA INHIBITORS SELF-ASSEMBLED IN SITU | THE SCRIPPS RESEARCH INSTITUTE | 2019-05-23 | — | — | US | disclosed |
| US-10220031-B2 | Toxic RNA inhibitors self-assembled in situ | THE SCRIPPS RESEARCH INSTITUTE (US) | 2019-03-05 | — | — | US | disclosed |
| US-20170143703-A1 | TOXIC RNA INHIBITORS SELF-ASSEMBLED IN SITU | THE SCRIPPS RESEARCH INSTITUTE | 2017-05-25 | — | — | US | disclosed |
| EP-3169404-A1 | TOXIC RNA INHIBITORS SELF-ASSEMBLED IN SITU | The Scripps Research Institute (US) | 2017-05-24 | — | — | EP | disclosed |
| CN-106714908-A | In situ self-assembled toxic RNA inhibitors | 斯克利普斯研究院 | 2017-05-24 | — | — | CN | disclosed |
| WO-2016011348-A1 | TOXIC RNA INHIBITORS SELF-ASSEMBLED IN SITU | THE SCRIPPS RESEARCH INSTITUTE (US) | 2016-01-21 | — | — | WO | disclosed |
| EP-0773950-B1 | LINKED PEPTIDE NUCLEIC ACIDS | ISIS PHARMACEUTICALS INC (US) | 2007-08-22 | — | — | EP | disclosed |
| US-7078406-B2 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) | 2006-07-18 | — | — | US | disclosed |
| US-7071195-B2 | Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2006-07-04 | — | — | US | disclosed |
| WO-2003031419-A1 | SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2003-04-17 | — | — | WO | disclosed |
| US-6451968-B1 | HOOGSTEEN TYPE BASE PAIRING IN TRIPLEX MOTIF; DIAGNOSIS; HEAT RESISTANCE; DETECTION OF POINT MUTATIONS, RESTRICTION ENZYME SITES, AND TRANSCRIPTION INHIBITION | ISIS PHARMACEUTICALS, INC. | 2002-09-17 | — | — | US | disclosed |
| US-6441130-B1 | FORM TRIPLE STRANDED STRUCTURES WITH NUCLEIC ACIDS | ISIS PHARMACEUTICALS, INC. | 2002-08-27 | — | — | US | disclosed |
| US-20020115715-A1 | Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders | DAX SCOTT L (US) | 2002-08-22 | — | — | US | disclosed |
| EP-1202986-A1 | AMINE AND AMIDE DERIVATIVES AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2002-05-08 | — | — | EP | disclosed |
| US-6380224-B1 | FOR THERAPY OF EATING DISORDERS, OBESITY, BULIMIA NERVOSA, DIABETES, MEMORY LOSS, EPILEPTIC SEIZURES, MIGRAINE, SLEEP DISTURBANCES, PAIN, SEXUAL/REPRODUCTIVE DISORDERS, DEPRESSION AND ANXIETY | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2002-04-30 | — | — | US | disclosed |
| WO-2001009120-A1 | AMINE AND AMIDE DERIVATIVES AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2001-02-08 | — | — | WO | disclosed |
| EP-0773950-A4 | LINKED PEPTIDE NUCLEIC ACIDS | ISIS PHARMACEUTICALS INC (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-0773950-A1 | LINKED PEPTIDE NUCLEIC ACIDS | ISIS PHARMACEUTICALS, INC. (US) | 1997-05-21 | — | — | EP | disclosed |
| WO-1996002558-A1 | LINKED PEPTIDE NUCLEIC ACIDS | ISIS PHARMACEUTICALS, INC. (US) | 1996-02-01 | — | — | WO | disclosed |